DALLAS, Aug. 3, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Novavax Inc. (Nasdaq:NVAX). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.
The investment report on Novavax Inc. (Nasdaq:NVAX) should be of particular interest to other biopharmaceutical companies: Crucell N.V (Nasdaq:CRXL), Merck & Co. Inc. (NYSE:MRK), Vical Inc. (Nasdaq:VICL) and Quidel Corp. (Nasdaq:QDEL).
It is available at: http://www.stockpreacher.com/n/NVAX
Novavax Inc. (NVAX) is a clinical-stage biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon preventive options for a range of infectious diseases. These vaccines leverage its virus-like particle (VLP) platform technology coupled with a disposable production technology. VLPs are genetically engineered three-dimensional nanostructures, which incorporate immunologically important lipids and recombinant proteins.
In the report, the analyst notes:
"Using its proprietary virus-like particle (VLP) technology, NVAX scientists build a structure similar to a virus except for the genetic material required for viral replication, without the use of an adjuvant. Once injected into the body, VLPs attach to cells and trigger an immune response sufficient enough to protect a person, if they are exposed to the virus. VLPs may have a number of advantages over traditional vaccines. Because they more closely match an individual viral strain, VLPs can trigger a more robust immune response.
"NVAX and the National Institutes of Health (NIH) signed an agreement to cooperate in the evaluation of a virus-like particle vaccine candidate against the novel influenza A (H1N1) virus. NVAX scientists produced the first batch of H1N1 VLPs within the company's laboratories in May, three weeks after the CDC announced the genetic sequence of a novel influenza A (H1N1) virus."
To read the entire report visit: http://www.stockpreacher.com/n/NVAX
StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com
StockPreacher.com Disclosure
StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly-owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.
CONTACT: StockPreacher.com
Jeff Bishop
(469)-252-3505
press@beaconequity.com
